Co-Diagnostics, Inc.
CODX
$0.56
$0.04639.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.00% | 0.98% | -22.65% | -148.15% | -380.65% |
| Total Depreciation and Amortization | 9.61% | 3.72% | -7.87% | -4.08% | 11.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.01% | -23.13% | -34.36% | -47.13% | 864.70% |
| Change in Net Operating Assets | -63.12% | -90.29% | -61.15% | -19.72% | 220.47% |
| Cash from Operations | -20.60% | -67.98% | -244.60% | -436.17% | -237.89% |
| Capital Expenditure | 4.53% | -1.24% | -31.13% | 4.36% | 4.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 159.47% | 158.69% | 164.48% | 129.53% | -1,141.98% |
| Cash from Investing | 155.58% | 154.49% | 161.06% | 126.46% | -1,153.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 93.41% | 97.42% | 94.00% | 90.40% | 81.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 93.41% | 97.42% | 93.99% | 90.28% | 81.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.78% | 100.04% | 118.38% | 87.72% | -6,096.14% |
